MedTrace Logo

A Study to Evaluate Changes in Smokers Using An Oral Tobacco-Derived Nicotine Product

NCT04079933 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 154

Last updated 2024-09-27

Study results available
· View outcomes & findings →

Summary

The purpose of this study was to estimate changes in biomarkers of exposure (BOE) in adult cigarette smokers using an oral tobacco-derived nicotine (OTDN) product relative to adult smokers who continue smoking exclusively.

Conditions

  • Tobacco Use

Interventions

OTHER

Oral tobacco-derived nicotine product (OTDN)

Sponsors & Collaborators

  • Altria Client Services LLC

    lead INDUSTRY

Principal Investigators

  • Jeffery S Edmiston, PhD · Altria Client Services LLC

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-27
Primary Completion
2013-11-26
Completion
2013-11-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04079933 on ClinicalTrials.gov